US Stock MarketDetailed Quotes

HSDT Helius Medical Technologies

Watchlist
  • 0.4882
  • +0.0280+6.08%
Close Nov 26 16:00 ET
  • 0.4950
  • +0.0068+1.39%
Post 19:49 ET
1.82MMarket Cap-114P/E (TTM)

Helius Medical Technologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-64.34%51K
-28.91%182K
21.62%135K
-18.17%644K
-52.48%134K
-27.04%143K
115.13%256K
-41.58%111K
50.77%787K
9.30%282K
Operating revenue
-69.70%40K
-29.92%171K
16.98%124K
-22.24%605K
-56.23%123K
-32.31%132K
105.04%244K
-42.08%106K
57.81%778K
11.95%281K
Cost of revenue
0.00%187K
-35.87%118K
0.82%123K
25.92%583K
-40.00%90K
85.15%187K
109.09%184K
-1.61%122K
55.37%463K
16.28%150K
Gross profit
-209.09%-136K
-11.11%64K
209.09%12K
-81.17%61K
-66.67%44K
-146.32%-44K
132.26%72K
-116.67%-11K
44.64%324K
2.33%132K
Operating expense
33.36%3.93M
1.31%3.33M
-9.77%3.43M
-18.25%12.33M
-18.24%2.29M
-29.61%2.95M
-4.91%3.29M
-17.95%3.8M
-17.88%15.08M
-33.80%2.8M
Selling and administrative expenses
29.78%2.85M
-4.36%2.46M
-8.39%2.63M
-12.87%9.27M
-17.03%1.63M
-35.28%2.2M
4.39%2.57M
1.95%2.87M
-12.61%10.64M
-17.21%1.97M
Research and development costs
49.17%1.08M
27.19%870K
-11.06%788K
-30.97%2.94M
-18.14%650K
-3.86%722K
-28.23%684K
-49.77%886K
-28.85%4.26M
-56.08%794K
Depreciation amortization depletion
-78.13%7K
-81.58%7K
-82.05%7K
-35.36%117K
-80.00%8K
-31.91%32K
-19.15%38K
-17.02%39K
-9.50%181K
-14.89%40K
-Depreciation and amortization
-78.13%7K
-81.58%7K
-82.05%7K
-35.36%117K
-80.00%8K
-31.91%32K
-19.15%38K
-17.02%39K
-9.50%181K
-14.89%40K
Operating profit
-35.94%-4.07M
-1.58%-3.27M
10.34%-3.42M
16.87%-12.27M
15.85%-2.25M
26.90%-2.99M
6.15%-3.22M
16.52%-3.81M
18.65%-14.76M
34.93%-2.67M
Net non-operating interest income expense
-101.47%-1K
-105.62%-5K
-108.00%-8K
130.82%257K
0
107.40%68K
89K
100K
-834K
85K
Total other finance cost
101.47%1K
105.62%5K
108.00%8K
-130.82%-257K
--0
-107.40%-68K
---89K
---100K
--834K
---85K
Other net income (expense)
152.24%385K
12.21%1.66M
-25.33%908K
107.89%3.16M
152.17%1.2M
-118.49%-737K
490.00%1.48M
457.80%1.22M
15,110.00%1.52M
-2.3M
Gain on sale of security
156.41%330K
7.42%1.59M
-29.77%854K
42.71%3.24M
148.87%1.13M
-112.34%-585K
490.00%1.48M
460.37%1.22M
22,610.00%2.27M
---2.31M
Special income (charges)
--0
----
----
79.00%-159K
--0
79.00%-159K
----
----
---757K
--0
-Less:Impairment of capital assets
--0
----
----
-79.00%159K
--0
-79.00%159K
----
----
--757K
--0
Other non- operating income (expenses)
685.71%55K
--71K
--54K
1,042.86%80K
1,116.67%73K
--7K
----
----
--7K
--6K
Income before tax
-0.63%-3.69M
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-0.63%-3.69M
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
Net income continuous Operations
-0.63%-3.69M
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
Minority interest income
Net income attributable to the parent company
-0.63%-3.69M
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-0.63%-3.69M
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
Basic earnings per share
81.97%-0.99
78.08%-0.64
30.32%-3.08
72.07%-14.56
88.71%-0.96
-89.31%-5.49
93.98%-2.92
92.31%-4.42
85.87%-52.13
87.02%-8.5
Diluted earnings per share
81.97%-0.99
78.08%-0.64
30.32%-3.08
72.07%-14.56
88.71%-0.96
-89.31%-5.49
93.98%-2.92
92.31%-4.42
85.87%-52.13
87.02%-8.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -64.34%51K-28.91%182K21.62%135K-18.17%644K-52.48%134K-27.04%143K115.13%256K-41.58%111K50.77%787K9.30%282K
Operating revenue -69.70%40K-29.92%171K16.98%124K-22.24%605K-56.23%123K-32.31%132K105.04%244K-42.08%106K57.81%778K11.95%281K
Cost of revenue 0.00%187K-35.87%118K0.82%123K25.92%583K-40.00%90K85.15%187K109.09%184K-1.61%122K55.37%463K16.28%150K
Gross profit -209.09%-136K-11.11%64K209.09%12K-81.17%61K-66.67%44K-146.32%-44K132.26%72K-116.67%-11K44.64%324K2.33%132K
Operating expense 33.36%3.93M1.31%3.33M-9.77%3.43M-18.25%12.33M-18.24%2.29M-29.61%2.95M-4.91%3.29M-17.95%3.8M-17.88%15.08M-33.80%2.8M
Selling and administrative expenses 29.78%2.85M-4.36%2.46M-8.39%2.63M-12.87%9.27M-17.03%1.63M-35.28%2.2M4.39%2.57M1.95%2.87M-12.61%10.64M-17.21%1.97M
Research and development costs 49.17%1.08M27.19%870K-11.06%788K-30.97%2.94M-18.14%650K-3.86%722K-28.23%684K-49.77%886K-28.85%4.26M-56.08%794K
Depreciation amortization depletion -78.13%7K-81.58%7K-82.05%7K-35.36%117K-80.00%8K-31.91%32K-19.15%38K-17.02%39K-9.50%181K-14.89%40K
-Depreciation and amortization -78.13%7K-81.58%7K-82.05%7K-35.36%117K-80.00%8K-31.91%32K-19.15%38K-17.02%39K-9.50%181K-14.89%40K
Operating profit -35.94%-4.07M-1.58%-3.27M10.34%-3.42M16.87%-12.27M15.85%-2.25M26.90%-2.99M6.15%-3.22M16.52%-3.81M18.65%-14.76M34.93%-2.67M
Net non-operating interest income expense -101.47%-1K-105.62%-5K-108.00%-8K130.82%257K0107.40%68K89K100K-834K85K
Total other finance cost 101.47%1K105.62%5K108.00%8K-130.82%-257K--0-107.40%-68K---89K---100K--834K---85K
Other net income (expense) 152.24%385K12.21%1.66M-25.33%908K107.89%3.16M152.17%1.2M-118.49%-737K490.00%1.48M457.80%1.22M15,110.00%1.52M-2.3M
Gain on sale of security 156.41%330K7.42%1.59M-29.77%854K42.71%3.24M148.87%1.13M-112.34%-585K490.00%1.48M460.37%1.22M22,610.00%2.27M---2.31M
Special income (charges) --0--------79.00%-159K--079.00%-159K-----------757K--0
-Less:Impairment of capital assets --0---------79.00%159K--0-79.00%159K----------757K--0
Other non- operating income (expenses) 685.71%55K--71K--54K1,042.86%80K1,116.67%73K--7K----------7K--6K
Income before tax -0.63%-3.69M2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M
Income tax 0000000000
Net income -0.63%-3.69M2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M
Net income continuous Operations -0.63%-3.69M2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M
Minority interest income
Net income attributable to the parent company -0.63%-3.69M2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -0.63%-3.69M2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M
Basic earnings per share 81.97%-0.9978.08%-0.6430.32%-3.0872.07%-14.5688.71%-0.96-89.31%-5.4993.98%-2.9292.31%-4.4285.87%-52.1387.02%-8.5
Diluted earnings per share 81.97%-0.9978.08%-0.6430.32%-3.0872.07%-14.5688.71%-0.96-89.31%-5.4993.98%-2.9292.31%-4.4285.87%-52.1387.02%-8.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data